Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$1.9M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
No filings held for this insider can be measured against the deadline.
The 33 most recent Form 4 transactions.
| Aug 3 | NRIX | Nurix Therapeutics, Inc. | MEXER◷ | 5,787 | $8.72 | $50.5K | +29.1% | Open the original filing on SEC.gov |
| Jul 30 | NRIX | Nurix Therapeutics, Inc. | MEXER◆ | 3,572 | — | — | — | Open the original filing on SEC.gov |
| Jul 30 | NRIX | Nurix Therapeutics, Inc. | MEXER◆ | 2,858 | — | — | — | Open the original filing on SEC.gov |
| Jul 30 | NRIX | Nurix Therapeutics, Inc. | MEXER◆ | 3,750 | — | — | — | Open the original filing on SEC.gov |
| Jul 30 | NRIX | Nurix Therapeutics, Inc. | SSELL | 3,847 | $23.38 | $90K | -16.2% | Open the original filing on SEC.gov |
| Jul 30 | NRIX | Nurix Therapeutics, Inc. | MEXER | 3,572 | — | — | +17.7% | Open the original filing on SEC.gov |
| Jul 30 | NRIX | Nurix Therapeutics, Inc. | MEXER | 2,858 | — | — | +16.5% | Open the original filing on SEC.gov |
| Jul 30 | NRIX | Nurix Therapeutics, Inc. | MEXER | 3,750 | — | — | +27.6% | Open the original filing on SEC.gov |
| Jul 2 | NRIX | Nurix Therapeutics, Inc. | MEXER◷◆ | 5,787 | — | — | — | Open the original filing on SEC.gov |
| Jul 2 | NRIX | Nurix Therapeutics, Inc. | MEXER◷◆ | 5,221 | — | — | — | Open the original filing on SEC.gov |
| Jul 2 | NRIX | Nurix Therapeutics, Inc. | SSELL◷ | 11,008 | $23.56 | $259.4K | -44.8% | Open the original filing on SEC.gov |
| Jul 2 | NRIX | Nurix Therapeutics, Inc. | MEXER◷ | 5,787 | $8.72 | $50.5K | +30.8% | Open the original filing on SEC.gov |
| Jul 2 | NRIX | Nurix Therapeutics, Inc. | MEXER◷ | 5,221 | $1.86 | $9.7K | +38.5% | Open the original filing on SEC.gov |
| Jun 25 | NRIX | Nurix Therapeutics, Inc. | MEXER◷◆ | 15,602 | — | — | — | Open the original filing on SEC.gov |
| Jun 25 | NRIX | Nurix Therapeutics, Inc. | MEXER◷◆ | 13,333 | — | — | — | Open the original filing on SEC.gov |
| Jun 25 | NRIX | Nurix Therapeutics, Inc. | SSELL◷ | 28,935 | $20.06 | $580.5K | -68.1% | Open the original filing on SEC.gov |
| Jun 25 | NRIX | Nurix Therapeutics, Inc. | MEXER◷ | 15,602 | $8.72 | $136K | +58.0% | Open the original filing on SEC.gov |
| Jun 25 | NRIX | Nurix Therapeutics, Inc. | MEXER◷ | 13,333 | $7.26 | $96.8K | +98.2% | Open the original filing on SEC.gov |
| Jun 2 | NRIX | Nurix Therapeutics, Inc. | MEXER◷◆ | 3,422 | — | — | — | Open the original filing on SEC.gov |
| Jun 2 | NRIX | Nurix Therapeutics, Inc. | SSELL◷ | 8,148 | $16.60 | $135.3K | -37.5% | Open the original filing on SEC.gov |
| Jun 2 | NRIX | Nurix Therapeutics, Inc. | MEXER◷ | 3,422 | $1.86 | $6.4K | +18.7% | Open the original filing on SEC.gov |
| May 4 | NRIX | Nurix Therapeutics, Inc. | SSELL◷ | 8,148 | $16.96 | $138.2K | -30.8% | Open the original filing on SEC.gov |
| May 1 | NRIX | Nurix Therapeutics, Inc. | SSELL◷ | 5,394 | $16.76 | $90.4K | -16.9% | Open the original filing on SEC.gov |
| Apr 30 | NRIX | Nurix Therapeutics, Inc. | MEXER◆ | 2,858 | — | — | — | Open the original filing on SEC.gov |
| Apr 30 | NRIX | Nurix Therapeutics, Inc. | MEXER◆ | 3,750 | — | — | — | Open the original filing on SEC.gov |
| Apr 30 | NRIX | Nurix Therapeutics, Inc. | MEXER◆ | 2,000 | — | — | — | Open the original filing on SEC.gov |
| Apr 30 | NRIX | Nurix Therapeutics, Inc. | SSELL | 3,214 | $16.65 | $53.5K | -9.2% | Open the original filing on SEC.gov |
| Apr 30 | NRIX | Nurix Therapeutics, Inc. | MEXER | 2,858 | — | — | +8.9% | Open the original filing on SEC.gov |
| Apr 30 | NRIX | Nurix Therapeutics, Inc. | MEXER | 3,750 | — | — | +13.2% | Open the original filing on SEC.gov |
| Apr 30 | NRIX | Nurix Therapeutics, Inc. | MEXER | 2,000 | — | — | +7.6% | Open the original filing on SEC.gov |
| Apr 2 | NRIX | Nurix Therapeutics, Inc. | SSELL◷ | 8,148 | $15.24 | $124.1K | -23.5% | Open the original filing on SEC.gov |